Upon the development of neutropenia, the primary intervention involved discontinuing ceftriaxone and administering granulocyte-colony stimulating factor (G-CSF), which facilitated a rapid recovery of neutrophil counts. This evidence concerns the gene CSF3 and Decreased total neutrophil count.